INTU vs. GMED
INTU (Intuit Inc.) and GMED (Globus Medical, Inc.) are both stocks. INTU operates in Software - Application (Technology), while GMED operates in Medical Devices (Healthcare). Over the past 10 years, INTU returned 12.10%/yr vs 12.86%/yr for GMED. Their 0.34 correlation means their historical movements had little consistent relationship.
Performance
INTU vs. GMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INTU achieves a -51.84% return, which is significantly lower than GMED's -9.76% return. Over the past 10 years, INTU has underperformed GMED with an annualized return of 12.10%, while GMED has yielded a comparatively higher 12.86% annualized return.
INTU
- 1D
- 0.18%
- 1M
- 18.87%
- 6M
- -36.17%
- YTD
- -51.84%
- 1Y
- -59.29%
- 3Y*
- -13.98%
- 5Y*
- -9.16%
- 10Y*
- 12.10%
- ALL TIME*
- 16.08%
GMED
- 1D
- -1.83%
- 1M
- 3.73%
- 6M
- -13.11%
- YTD
- -9.76%
- 1Y
- 49.71%
- 3Y*
- 10.13%
- 5Y*
- -1.08%
- 10Y*
- 12.86%
- ALL TIME*
- 13.68%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $96.46M | $126.87M | $149.45M | |
INTU Intuit Inc. | $1.23B | $1.26B | $1.61B |
INTU vs. GMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INTU Intuit Inc. | -51.84% | 6.09% | 1.16% | 61.76% | -39.12% | 70.27% | 46.12% | 34.11% | 25.86% | 39.21% |
GMED Globus Medical, Inc. | -9.76% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
Correlation
The correlation between INTU and GMED is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.35 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.37 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012 | 0.34 |
Over the past year, the correlation between INTU and GMED has dropped to 0.13 - well below their long-term average of 0.34, suggesting their price drivers have been diverging.
Fundamentals
INTU:
$86.46B
GMED:
$10.63B
INTU:
$16.41
GMED:
$4.28
INTU:
19.26
GMED:
18.39
INTU:
1.15
GMED:
0.19
INTU:
4.22
GMED:
3.48
INTU:
4.23
GMED:
2.30
INTU:
$20.93B
GMED:
$3.10B
INTU:
$16.97B
GMED:
$1.58B
INTU:
$6.65B
GMED:
$803.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INTU vs. GMED — Risk / Return Rank
INTU
GMED
INTU vs. GMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Intuit Inc. (INTU) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INTU | GMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.27 | ||
| Sortino ratioReturn per unit of downside risk | -4.27 | ||
| Omega ratioGain probability vs. loss probability | 0.74 | 1.26 | -0.52 |
| Calmar ratioReturn relative to maximum drawdown | -0.88 | 2.26 | -3.14 |
| Martin ratioReturn relative to average drawdown | -1.49 | 4.92 | -6.41 |
Loading charts...
Drawdowns
INTU vs. GMED - Drawdown Comparison
The maximum INTU drawdown since its inception was -75.29%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for INTU and GMED.
Loading charts...
Drawdown Indicators
| INTU | GMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.29% | -47.91% | -27.38% |
Max Drawdown (1Y)Largest decline over 1 year | -67.28% | -22.10% | -45.18% |
Max Drawdown (3Y)Largest decline over 3 years | -68.19% | -44.40% | -23.79% |
Max Drawdown (5Y)Largest decline over 5 years | -68.19% | -47.91% | -20.28% |
Max Drawdown (10Y)Largest decline over 10 years | -68.19% | -47.91% | -20.28% |
Current DrawdownCurrent decline from peak | -60.41% | -18.62% | -41.79% |
Average DrawdownAverage peak-to-trough decline | -24.30% | -15.35% | -8.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 39.92% | 10.13% | +29.79% |
Volatility
INTU vs. GMED - Volatility Comparison
Intuit Inc. (INTU) has a higher volatility of 14.50% compared to Globus Medical, Inc. (GMED) at 12.47%. This indicates that INTU's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INTU | GMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.50% | 12.47% | +2.03% |
Volatility (6M)Calculated over the trailing 6-month period | 43.81% | 26.28% | +17.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.33% | 49.44% | -2.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.29% | 38.45% | -0.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.35% | 35.41% | -1.06% |
Dividends
INTU vs. GMED - Dividend Comparison
INTU's dividend yield for the trailing twelve months is around 1.52%, while GMED has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
INTU Intuit Inc. | 1.52% | 0.65% | 0.60% | 0.52% | 0.72% | 0.38% | 0.57% | 0.74% | 0.83% | 0.89% | 1.08% | 1.09% |
Financials
INTU vs. GMED - Financials Comparison
This section allows you to compare key financial metrics between Intuit Inc. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INTU vs. GMED - Profitability Comparison
INTU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Intuit Inc. reported a gross profit of 7.24B and revenue of 8.56B. Therefore, the gross margin over that period was 84.6%.
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
INTU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Intuit Inc. reported an operating income of 4.02B and revenue of 8.56B, resulting in an operating margin of 47.0%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
INTU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Intuit Inc. reported a net income of 3.06B and revenue of 8.56B, resulting in a net margin of 35.8%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
Frequently Asked Questions
INTU and GMED have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INTU has higher volatility (14.50%) compared to GMED (12.47%). In terms of maximum drawdown, INTU dropped -75.29% vs GMED's -47.91%.
GMED currently has the higher Sharpe Ratio (1.01 vs -1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INTU and GMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer